The findings.

The findings, published in the journal Proceedings of the National Academy of Sciences , the cooperation between the University? de Montreal, McGill University and the Montreal Neurological Institute in Canada and the University? de Namur in Belgium. The researchers show how an unusual molecule, called proNGF, glial cells, which normally activated to protect neurons in the retina and brain. – We found that glial cells and attack to kill neurons after it triggered by proNGF, says co-author Dr. Philip Barker, a neuroscientist at the Montreal Neurological Institute and a professor at the McGill Department of Neurology and Neurosurgery. To Since glial cells normally protect neurons, we were surprised that proNGF can glia into killers, neurons neuron lead to death in the retina convert.

Nevertheless, flu can cause serious illness and sometimes death in the elderly and other vulnerable people. An outbreak is also a significant burden on hospitals, as the number of people admitted always increases during an outbreak, not just for breathing problems, but for a variety of other medical conditions. In cooler countries, all of this known ‘that backed by a number of statistical studies? ‘For many years? However, it was assumed that the flu only a small problem for people in the warmer parts of the world? ‘In the tropics and subtropics. Most countries in these regions , developing countries, and the collection and analysis of data on influenza and its complications are not.Prostate Specific Antigen velocities Selective clinically significant prostate cancer in screening of?

PSAV has been shown to be predictive of an adverse patient outcome to patients who are already diagnosed with prostate. The value of all PSAV as a pre – biopsy factor in has not yet established. From Tineke Wolters, Monique J. Chris H. Bangma and Fritz H. Oblique the as part of of Beyond the summary on UroToday.com Posted.

Link to the full AbstractUroToday – the only one urological site with original content on global Urologist key opinion leader written written clinical practices.